Draft:Anjay Rastogi

Chief Neprhologist and Kidney Disease advocate at UCLA From Wikipedia, the free encyclopedia

Anjay Rastogi (MD, PhD) is an American nephrologist, pharmacologist, and medical humanitarian,[1] known for his contributions to kidney health, clinical research, and public health outreach. Rastogi has been associated with the University of California, Los Angeles since 1994.[2]


Quick facts Anjay Rastogi, Alma mater ...
Close

Early Life and Education

Dr. Rastogi, (MD, PhD) was born on February 6th, 1969 in Jaipur, India. His inspiration to pursue medicine can be traced back to his late father, who was also a doctor. His father, a compassionate figure, demonstrated humanity by actively helping his village and accepting their offerings, which he generously returned through medical treatment.[3]

Raised by his grandmother, Dr. Rastogi attended St. Xavier's Catholic School in Jaipur, where he had the privilege of meeting Mother Teresa, an encounter that left a lasting impact on his humanitarian values.

Once he pursued higher education in India, Dr. Rastogi had the opportunity to work under Nobel laureate Louis José Ignarro, further fueling his passion for research and medical excellence.[4]

He obtained a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree from the University of Rajasthan in Jaipur, India, and subsequently earned a Doctor of Medicine (MD) degree from SMS Medical College.[5]

Dr. Rastogi furthered his academic pursuits by earning a doctorate (PhD) in Pharmacology at the David Geffen School of Medicine at UCLA, specializing in the Department of Molecular and Medical Pharmacology. He then finished his education doing his internal medicine residency and nephrology fellowship at UCLA.[6]

Academic and clinical leadership

UCLA affiliations

In 2016, Dr. Rastogi (MD, PhD) founded the UCLA CORE Kidney Health Program, which focuses on advancing kidney health awareness and treatment strategies through integrated care, with an emphasis on prevention and education to empower patients to become active advocates for their own health. He still remains as the director to this day.[7]With the creation of the CORE Kidney Program also came the Circle of CORE. The Circle of CORE is a patient advocacy and support organization composed of current and former kidney patients that work to provide peer support, patient education, and advocacy for the kidney health community.[8]

Through CORE Kidney, Dr. Rastogi has also been heavily involved in community engagement and outreach events in order to bring kidney health education to patients everywhere.[9]


He has served as a Professor of Medicine at the David Geffen School of Medicine at UCLA since 2016 along with other various leadership roles:

  • Director of Clinical Research Program at UCLA[5]
  • Director of ADPKD, Fabry, and Alport Programs at UCLA[5]
  • Director of Hypertension Program at UCLA[5]
  • Director of Diabetic Kidney Disease Program at UCLA[5]
  • Director of Diet & Nutrition and Kidney Disease Programs at UCLA[5]
  • Director of ESRD / Dialysis Program at UCLA[5]
  • Director of Living Donor Program at UCLA
  • Director of Nephro-Genetics Program at UCLA[5]
  • Clinical Chief of UCLA Nephrology, UCLA Health System[5]
  • Medical Director of DaVita Century City and Brentwood Dialysis Units[5]

He also leads national studies, including the 2022–present Vertex Study and the 2020–present ALIGN Study for the CHINOOK study.

Awards and recognition

  • 2014, Exceptional MD of the Year UCLA Health[10]
  • 2017, Postdoctoral Mentoring Award
  • 2019, Greater Los Angeles Top Doctors
  • 2021, George Lopez Foundation Nephrology Hero Award[11]
  • 2022, Pasadena, CA Top Doctors[12]
  • 2023, Los Angeles Business Journal Top Doctors[13]
  • 2023, Younes Nazarian Medical Humanitarian Prize[14]
  • 2024, Southern California Super Doctors[15]
  • 2024, Isabella Coleman Award for Rose Parade Float [16]

Research and professional contributions

Dr. Rastogi (MD, PhD) has been an active contributor to the field of nephrology, consistently publishing research findings that advance our understanding of kidney diseases. Here are six of his recent publications:

Selected publications

  • Shye, Michael; Sisk, Anthony; Schulze, Carl; Barsoum, Marina; Mikhail, Mira; Arman, Farid; Rastogi, Anjay; Hanna, Ramy M. (June 2020). "A case of renal and splenic LECT2 amyloidosis, a recently recognized cause of renal and systemic amyloidosis". Clinical Nephrology. 31 (2): 508–514. doi:10.4103/1319-2442.284027. PMID 32394925.
  • Khorsan, Reza; Hanna, Ramy M.; Ameen, Khalid; Arman, Farid; Nobakht, Niloofar; Hasnain, Huma; Hyunh, Ashley; Rastogi, Anjay (March 2019). "Primary membranous nephropathy with concomitant IgA nephropathy". Saudi Journal of Kidney Diseases and Transplantation. 30 (2): 531–536. doi:10.4103/1319-2442.256863. PMC 6454780. PMID 31007705.
  • Rastogi, Anjay; Lerma, Edgar V. (2021-03-18). "Anemia management for home dialysis including the new public policy initiative". Kidney International Supplements. 11 (1): 59–69. doi:10.1016/j.kisu.2020.12.005. PMC 8015116. PMID 33817521.
  • Fishbane, Steven; Ford, Martin; Fukagawa, Masafumi; McCafferty, Kieran; Rastogi, Anjay; Spinowitz, Bruce; Staroselskiy, Konstantin; Vishnevskiy, Konstantin; Lisovskaja, Vera; Al-Shurbaji, Ayman; Guzman, Nicolas; Bhandari, Sunil (2022-02-08). "Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients". BMC Nephrology. 23 (4): 614–619. doi:10.1186/s12882-021-02569-7. PMID 35135643.
  • Spinowitz, Bruce; Fishbane, Steven; Fukagawa, Masafumi; Ford, Martin; Guzman, Nicolas; Rastogi, Anjay (2022-04-28). "Course of hyperkalemia in patients on hemodialysis". International Journal of Nephrology. 15: 1–11. doi:10.1155/2022/6304571. PMC 9026311. PMID 35465095.
  • Rastogi, Anjay; Hanna, Ramy M.; Mkrttchyan, Anita; Khalid, Maham; Yaqoob, Sinan; Shaffer, Kelly; Dhawan, Puneet; Nobakht, Niloofar; Kamgar, Mohammad; Goshtaseb, Ray; Sarmosyan, Kristine; Gnarini, Mariarosaria; Wassef, Olivia; Lerma, Edgar V. (2021-07-06). "Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease: a novel agent". Expert Review of Clinical Pharmacology. 14 (9): 1055–1064. doi:10.1080/17512433.2021.1932460. PMID 34184570.

Personal initiatives

Dr. Rastogi (MD, PhD) founded the Bruin Beans Health Club at UCLA in 2015, a health and wellness initiative with outreach activities ranging from local to global communities. This undergraduate club assists the CORE Kidney program with improving healthcare delivery to patients with kidney disease by implementing CORE values of Clinical excellence, Outreach, Research, and Education as well as promoting awareness for kidney health in general at various outreach events.[17]

References

Related Articles

Wikiwand AI